Risk factor
Weak & very vulnerable to price shocks
Profitability factor
Very low or no dividends
About
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on the development of treatments for multiple therapeutic areas, such as rare...
Company Valuation
Based on key historical and expected multiples, the stock is fairly valued relative to its peers. In particular, the stock is underpriced on P/E, of fair value on EV/EBIT
Target Price
The average target price of PTCT is 86 and suggests 29% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increase
Buy
Sell